Hims & Hers Health, Inc. (HIMS)

Hims & Hers Health Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Hims & Hers Health stock have an average target of 38.25, with a low estimate of 22 and a high estimate of 68. The average target predicts an increase of 40.52% from the current stock price of 27.22.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$22	$38.25	$35	$68
Change	-19.18%	+40.52%	+28.58%	+149.82%

Analyst Ratings

The average analyst rating for Hims & Hers Health stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	6	6	6	5	4	4
Buy	0	1	1	0	0	0
Hold	6	6	5	7	6	6
Sell	1	1	1	1	1	1
Strong Sell	0	0	1	1	1	1
Total	13	14	14	14	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jailendra Singh Truist Securities	Truist Securities	Hold Maintains $39 → $33	Hold	Maintains	$39 → $33	+21.23%	Apr 10, 2025
Allen Lutz B of A Securities	B of A Securities	Sell Maintains $21 → $22	Sell	Maintains	$21 → $22	-19.18%	Mar 18, 2025
Allen Lutz B of A Securities	B of A Securities	Sell Reiterates $21	Sell	Reiterates	$21	-22.85%	Mar 6, 2025
Daniel Grosslight Citigroup	Citigroup	Strong Sell Reiterates $27	Strong Sell	Reiterates	$27	-0.81%	Mar 6, 2025
Jailendra Singh Truist Securities	Truist Securities	Hold Maintains $24 → $39	Hold	Maintains	$24 → $39	+43.28%	Feb 26, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.35B

Increased by 59.29%

from 1.48B

Revenue Next Year

2.78B

Increased by 18.03%

from 2.35B

EPS This Year

0.62

Increased by 16.02%

from 0.53

EPS Next Year

0.89

Increased by 43.41%

from 0.62

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	148.76M	271.88M	526.92M	872.00M	1.48B	2.35B	2.78B	3.44B
Revenue Growth	80.19%	82.77%	93.81%	65.49%	69.33%	59.29%	18.03%	23.78%
EPS	-0.51	-0.58	-0.32	-0.11	0.53	0.62	0.89	1.27
EPS Growth	-	-	-	-	-	16.02%	43.41%	43.97%
Forward PE	-	-	-	-	-	44.08	30.74	21.35
No. Analysts	-	-	-	-	-	17	15	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	2.5B	3.2B	4.2B
Avg	2.4B	2.8B	3.4B
Low	1.9B	1.9B	2.9B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	69.8%	35.1%	49.5%
Avg	59.3%	18.0%	23.8%
Low	29.1%	-19.7%	4.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	0.93	1.73	2.18
Avg	0.62	0.89	1.27
Low	0.21	0.28	0.89

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	75.6%	180.6%	146.6%
Avg	16.0%	43.4%	44.0%
Low	-61.3%	-54.0%	0.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.